Point72 Asia (Singapore) Pte. Ltd. Cytek Biosciences, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 15,771 shares of CTKB stock, worth $54,883. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,771
Previous 11,364
38.78%
Holding current value
$54,883
Previous $73.8 Million
14.25%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CTKB
# of Institutions
160Shares Held
73.8MCall Options Held
600Put Options Held
4.9K-
Black Rock Inc. New York, NY17.1MShares$59.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.62MShares$33.5 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD7.46MShares$26 Million0.93% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$23.2 Million0.82% of portfolio
-
State Street Corp Boston, MA4.38MShares$15.2 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $469M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...